Jan Koenig, MD
Orthopedic Surgery · Rockville Centre, NYNPI 1245221209
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $1,360,605 of the $1,397,397 with a category attached, or 97.4%. Omnilife Science, Inc accounts for 100.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2021 at $352,788 and has fallen 82.4% since, to $62,040 in 2025. Among orthopedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $20,550 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Omnilife Science, Inc$1.4M
- Ferring Pharmaceuticals Inc.$163
- Johnson & Johnson$143
- Corin USA$131
- Medacta USA, Inc.$59
Across 12 payments — averaging $3185.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Omnilife Science, Inc$38K
What the payments were for
- Royalty or licence$1,360,60597%
- Consulting fees$31,2002%
- Travel & lodging$4,4160%
- Food & beverage$1,1760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Omnilife Science, Inc | 50 | $1,396,902 |
| Ferring Pharmaceuticals Inc. | 9 | $163 |
| Johnson & Johnson | 7 | $143 |
| Corin USA | 1 | $131 |
| Medacta USA, Inc. | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNIBOTICS$620,805
- OMNIBotics v 2.7$294,720
- OMNIBotics 3.0$223,570
How this compares
$1,397,397 in reported general payments places this provider in the 95th percentile of 91 orthopedic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 195 | $395 |
| Methylprednisolone | 25 | $141 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Rockville Centre
- Baron LonnerNew York$2.1M
- Lon WeinerNew York$622K
- Andrew CappuccinoLockport$581K
- Douglas PadgettUniondale$407K
- James GladstoneNew York$260K
- Thomas WickiewiczNew York$201K
- David EssigNew York$123K
- Jason McKeanBrooklyn$61K
- Daniel ZuchelliBrooklyn$25K
- Victor KatzNew Hyde Park$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.